UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

The New England journal of medicine, 2023-01, Vol.388 (1), p.89-91

2023

Volltextzugriff (PDF)

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

The New England journal of medicine, 2022-08, Vol.387 (5), p.468-470

2022

Volltextzugriff (PDF)

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

The New England journal of medicine, 2022-04, Vol.386 (15), p.1475-1477

2022

Volltextzugriff (PDF)

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

The New England journal of medicine, 2022-03, Vol.386 (10), p.995-998

2022

Volltextzugriff (PDF)

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Proceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (28), p.16587-16595

2020

Volltextzugriff (PDF)

Comparison of Rapid Antigen Tests for COVID-19

Viruses, 2020-12, Vol.12 (12), p.1420

2020

Volltextzugriff (PDF)

Favorite Parts of a Single Leaf for Giant Flying Squirrels to Eat in Three Species of Food Trees

Biology (Basel, Switzerland), 2023-10, Vol.12 (10), p.1352

2023

Volltextzugriff (PDF)

Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

Nature (London), 2022-12, Vol.612 (7940), p.540-545

2022

Volltextzugriff (PDF)

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75

The New England journal of medicine, 2022-09, Vol.387 (13), p.1236-1238

2022

Volltextzugriff (PDF)

Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans

Emerging infectious diseases, 2018-04, Vol.24 (4), p.746-750

2018

Volltextzugriff (PDF)

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1

The Lancet infectious diseases, 2023-05, Vol.23 (5), p.525-526

2023

Volltextzugriff (PDF)

Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene

Cell host & microbe, 2018-10, Vol.24 (4), p.569-578.e4

2018

Volltextzugriff (PDF)

Different Responses of Endemic and Alien Tree Squirrels to Tree Seed Chemicals

MAMMAL STUDY, 2021-07, Vol.46 (3), p.237-250

2021

Volltextzugriff (PDF)

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6

The New England journal of medicine, 2022-12, Vol.387 (22), p.2094-2097

2022

Volltextzugriff (PDF)

A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols

mSphere, 2022-04, Vol.7 (2), p.e0094121

2022

Volltextzugriff (PDF)

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

EClinicalMedicine, 2021-02, Vol.32, p.100734-100734, Article 100734

2021

Volltextzugriff (PDF)

Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses

Journal of general virology, 2019-10, Vol.100 (10), p.1345-1349

2019

Volltextzugriff (PDF)

Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113580-113580, Article 113580

2023

Volltextzugriff (PDF)

Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010085-e1010085

2021

Volltextzugriff (PDF)

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Nature communications, 2023-03, Vol.14 (1), p.1620-1620, Article 1620

2023

Volltextzugriff (PDF)

Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model

Viruses, 2023-11, Vol.15 (12), p.2280

2023

Volltextzugriff (PDF)

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

Emerging infectious diseases, 2022-11, Vol.28 (11), p.2198-2205

2022

Volltextzugriff (PDF)

Mammalian adaptive mutations of the PA protein of highly pathogenic avian H5N1 influenza virus

Journal of virology, 2015-04, Vol.89 (8), p.4117-4125

2015

Volltextzugriff (PDF)

Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion

Journal of Virology, 2012-02, Vol.86 (3), p.1405-1410

2012

Volltextzugriff (PDF)

1 – 25 von 411

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(326)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(172)
Humans
(86)
Animals
(62)
Virology
(37)
Female
(30)
Infectious Diseases
(28)
Microbiology
(27)
Mice
(26)
Biochemistry & Molecular Biology
(24)
Biological And Medical Sciences
(24)
Severe Acute Respiratory Syndrome Coronavirus 2
(23)
Viruses
(23)
Coronaviruses
(21)
Influenza
(21)
Mutation
(21)
Physical Sciences
(21)
Covid-19
(20)
Chemistry
(18)
General & Internal Medicine
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Comparison of Rapid Antigen Tests for COVID-19

Favorite Parts of a Single Leaf for Giant Flying Squirrels to Eat in Three Species of Food Trees

Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75

Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans

A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1

Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene

Different Responses of Endemic and Alien Tree Squirrels to Tree Seed Chemicals

In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6

A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols

Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses

Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo

Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022

Mammalian adaptive mutations of the PA protein of highly pathogenic avian H5N1 influenza virus

Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion

Aktive Filter

Suchergebnisse filtern